PCR pour le marché du diagnostic des infections respiratoires – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00023326
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 284
Buy Now

Le marché de la PCR pour le diagnostic des infections respiratoires était évalué à 8 279,32 millions de dollars US en 2028, contre 4 146,02 millions de dollars US en 2021 ; on estime qu'il augmentera à un TCAC de 10,4 % de 2021 à 2028.



La réaction en chaîne de la polymérase (PCR) est utilisée pour des diagnostics précis au point de service qui aident à identifier et à déterminer rapidement la cause des infections des voies respiratoires. En outre, la PCR est largement préférée dans les milieux hospitaliers et ambulatoires qui contribuent à améliorer la croissance du marché ces dernières années.



La croissance de la PCR pour le marché du diagnostic des infections respiratoires est attribuée à des facteurs tels que la charge croissante des maladies respiratoires chroniques (MRC), les développements croissants des tests PCR, améliorent largement les performances des dispositifs médicaux. Cependant, l'utilisation des tests PCR pour divers diagnostics d'infections respiratoires et les développements de la technologie PCR sont utilisés pour les dériver. La disponibilité de tests alternatifs entrave la croissance du marché.



Régions lucratives pour la PCR pour le marché du diagnostic des infections respiratoires



Aperçu du marché



Stratégies de consolidation du marché adoptées par l'utilisation de la PCR Tests pour divers diagnostics d'infections respiratoires



Le test PCR est l'étalon-or pour détecter les maladies infectieuses respiratoires, y compris le SRAS-CoV-2. De plus, les développements croissants de la PCR ne se limitent pas aux tests COVID-19. Les développements technologiques continus ont permis aux chercheurs de développer des techniques avancées de PCR à un coût réduit et de limiter leurs complexités. On s'attend à ce que les tests PCR améliorent leurs capacités de diagnostic moléculaire et renforcent leur rôle à l'avenir avec les développements en cours de technologies telles que la microfluidique et le séquençage de nouvelle génération. En outre, les tests PCR sont largement utilisés dans les institutions telles que les maisons de retraite, les établissements de soins chroniques et les hôpitaux, pour identifier l'infection par le virus de la grippe qui provoque des épidémies respiratoires.



De plus, les infections respiratoires aiguës et chroniques sont parmi les principales causes de morbidité dans les pays développés et en développement à l'échelle mondiale. On estime que les maladies respiratoires aiguës représentent près de 75 % du total des morbidités aiguës dans le monde. Par conséquent, diverses entreprises proposent divers kits PCR capables de détecter la présence d'agents pathogènes à l'origine de maladies respiratoires. Par exemple, des sociétés telles que bioMérieux SA et altona Diagnostics GmbH proposent une large gamme de kits PCR capables de détecter une infection respiratoire aiguë dans les voies respiratoires supérieures ou inférieures. Outre l'incidence croissante des maladies respiratoires aiguës et chroniques, d'autres facteurs tels que les conditions environnementales et climatiques, la pollution de l'air et les découvertes de nouvelles bactéries, virus et agents pathogènes sont susceptibles de constituer des opportunités de croissance vitales pour les tests PCR pour le diagnostic des infections respiratoires dans l'avenir à venir.



Type -Based Insights



Le marché de la PCR pour le diagnostic des infections respiratoires, par type, est segmenté en PCR en temps réel (qPCR), PCR multiplex, PCR traditionnelle, numérique PCR, transcriptase inverse (RT-PCR) et autres. Le segment de la PCR en temps réel (qPCR) détenait la plus grande part du marché en 2021 et devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



PCR pour le marché du diagnostic des infections respiratoires, par type - 2021 et 2028



Insights basés sur le type de produit



En fonction du type de produit, le marché de la PCR pour le diagnostic des infections respiratoires est segmenté en réactifs et kits, instruments et autres. Le segment des réactifs et des kits détenait la plus grande part du marché en 2021 et devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Informations basées sur le type d'infection



En fonction du type d'infection, le marché de la PCR pour le diagnostic des infections respiratoires est segmenté en infections bactériennes, virales, fongiques et autres agents pathogènes. En 2021, le segment des infections virales détenait la plus grande part du marché et devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Insights basés sur les utilisateurs finaux



Basé sur l'utilisateur final, le marché de la PCR pour le diagnostic des infections respiratoires est segmenté en hôpitaux, cliniques médicales, laboratoires cliniques, institutions universitaires et de recherche, biotechnologie et industrie pharmaceutique entreprises, et autres. En 2020, le segment des laboratoires cliniques détenait la plus grande part du marché et on estime qu'il a enregistré le TCAC le plus élevé du marché au cours de la période de prévision.



Perspectives stratégiques



Lancements et approbations de produits sont les stratégies couramment adoptées par les entreprises pour étendre leur empreinte mondiale et leurs portefeuilles de produits. De plus, les acteurs du marché de la reconstruction mammaire se concentrent sur la stratégie de collaboration pour élargir leur clientèle, ce qui, à son tour, leur permet de maintenir leur marque à l'échelle mondiale.



Par type




  • PCR en temps réel (qPCR)

  • PCR multiplex

  • PCR traditionnelle

  • PCR numérique

  • Reverse-Transcriptase (RT-PCR)

  • Autres



Par type de produit




  • Réactifs et kits

  • Instruments

  • Autres



Par type d'infection




  • Infections bactériennes

    • Bordetella

    • Streptococcus Pneumoniae

    • Staphylococcus Aureus

    • Haemophilus Influenzae

    • Moraxella Catarrhalis

    • Mycoplasma Pneumoniae

    • Chlamydophila Pneumoniae

    • Légionnelle
    • < li>Autres

  • Infections virales

    • Rhinovirus

    • Virus de la grippe

    • Syndrome respiratoire aigu sévère (SRAS) Virus CoV-2

    • Virus respiratoire syncytial (VRS)

    • Adénovirus

    • Entérovirus

    • Parainfluenza

    • Métapneumovirus humain (hMPV)

    • Autres


  • Fongiques et autres agents pathogènes



Par utilisateur final



  • Hôpitaux

  • Cliniques médicales

  • Laboratoires cliniques

  • Institutions universitaires et de recherche

  • Entreprises biotechnologiques et pharmaceutiques
  • < li>Autres


Par géographie




  • Amérique du Nord

    • États-Unis

    • Canada

    • Mexique


  • Europe

    • France

    • Allemagne

    • Royaume-Uni

    • Espagne
    • Pays-Bas

    • Norvège

    • Italie

    • Reste de l'Europe


  • Asie-Pacifique ( APAC)

    • Chine

    • Inde

    • Japon

    • Australie

    • Corée du Sud

    • Reste de l'Asie-Pacifique


  • Moyen-Orient et Afrique (MEA)

    • Arabie saoudite

    • EAU

    • Afrique du Sud

    • Reste du Moyen-Orient et Afrique


  • Amérique du Sud et centrale (SCAM)

    • Brésil

    • Argentine

    • Reste de l'Amérique du Sud et centrale




Profils des entreprises




  • Abbott
  • < li>F. Hoffmann-La Roche AG
  • Hologic, Inc.

  • Seegene Inc.

  • AusDiagnostics

  • BD

  • Bio -Rad Laboratories Inc

  • BioMérieux

  • Qiagen

  • Thermo Fisher Scientific Inc

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is PCR test mean?

The polymerase chain reaction (PCR) is a simple and low-cost method for amplifying small portions of DNA. Because significant amounts of a sample of DNA are necessary for molecular and genetic analyze, studies of isolated fragments of DNA are almost impossible without PCR amplification.

What are the driving factors for the PCR for respiratory infection diagnostics market across the globe?

The growth of the market is attributed to some key driving factors such as as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth. In January 2020, Roche received CE Mark approval for an adenovirus test for transplant patients. It is intended to be used in conjunction with other infectious diseases tests available on their cobas systems (6800 and 8800). The majority of companies are now offering real-time polymerase chain reaction (PCR) tests for corona virus, which is contributing to the growth of the target market.Such strategic steps are also projected to drive the market growth.

What is the regional analysis in terms of PCR for respiratory infection diagnostics?

The growth of the region is attributed to factors such as rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical devices. Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in Asia Pacific. In addition, the Europe is expected account for the fastest growth in the PCR for respiratory infection diagnostics market. A high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical devices growth of Europe PCR for respiratory infection diagnostics market during the forecast period.

The List of Companies - PCR for Respiratory Infection Diagnostic Market

  1. Abbott
  2. F. Hoffmann-La Roche AG
  3. Hologic, Inc.
  4. Seegene Inc.
  5. AusDiagnostics
  6. BD
  7. Bio-Rad Laboratories Inc
  8. BioMérieux
  9. Qiagen
  10. Thermo Fisher Scientific Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports